コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 polyester fabrics, although with 3- 6% lower add-on.
3 001; LABA = 1.01, 0.92-1.11, p = 0.87, other add-on = 1.00, 0.91-1.09, p = 0.79) and no increase in r
4 s provided by activated methylenes have been added on 3-(2-nitrovinyl)-1H-indole in very good to exce
9 orvastatin, 80 mg; add-on ezetimibe therapy; add-on alirocumab therapy, 75 mg (a PCSK9 inhibitor); an
11 were randomized (2:1) to receive DCVAC/PCa (add-on and maintenance) or placebo, both in combination
13 tify all randomized controlled trials of any add-on antidepressants compared with placebo or no-treat
15 e is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin-conv
16 at treatment discontinuation, initiation of add-on antipsychotics, death, and end of database linkag
18 in 16 of 85 (19%) patients allocated to the add-on arm versus 9 of 90 (10%) in the monotherapy arm (
20 ayment System bundling, but not the training add-on, associated with substantial increases in home di
21 rval [CI], 1.01-1.61), intermittent ICS plus add-on asthma medication use (HR, 2.00; 95% CI, 1.43-2.7
22 top 3 quartiles would prevent 9.4 deaths and add, on average, 2.1 days to life expectancy at an incre
28 icated biopsy machines or incorporated into "add-on" biopsy devices for existing PET or SPECT cameras
29 elines recommended standalone, emerging, and add-on cardiac biomarkers, as well as their combinations
33 work shows the potential of the viscoelastic add-on components as lightweight and cost-effective solu
34 o test the effectiveness of new viscoelastic add-on components in decreasing biomechanical forces wit
35 ser desorption imaging interface composed of add-on components that adapt a commercial Desorption Ele
43 ficantly expands the textile design space by adding on-demand and programmable 3D structural morphing
45 as compared with control interventions) from add-on designs (in which an experimental intervention ad
47 onversely, in both populations, the training add-on did not associate with increases in home dialysis
49 bined with binding assays indicate that this add-on domain contributes to forming an active GtfA-GtfB
50 These findings suggest that fusion with an add-on domain might be a universal mechanism for diverse
53 ine (retigabine) was recently approved as an add-on drug for the treatment of partial seizures in adu
56 phase 3 LIBERTY ASTHMA QUEST (NCT02414854), add-on dupilumab 200/300 mg every 2 weeks (q2w) reduced
57 02414854) to TRAVERSE (NCT02134028) received add-on dupilumab 300 mg every 2 weeks for up to 96 weeks
58 oderate-to-severe asthma, those who received add-on dupilumab had fewer asthma exacerbations and bett
59 hemispheric tDCS cannot be explained by mere add-on effects of anodal and concurrent cathodal stimula
60 how that alteration of a discrete structural add-on element on the toxin drives specific recognition
61 In this study we tested the hypothesis that add-on EPA has greater antidepressant efficacy in MDD pa
63 applied: uptitration to atorvastatin, 80 mg; add-on ezetimibe therapy; add-on alirocumab therapy, 75
66 rst of its class for an approved indication, add on if a drug was approved in combination with a prev
67 amylamine, has been shown to be an effective add-on in patients that do not respond to selective sero
70 The efficacy of BCI-monitored MI practice as add-on intervention to usual rehabilitation care was eva
73 aft and regional lymphoid tissue [Correction added on January 9, 2019, after first online publication
75 plasmonic nanoscale construct serving as an 'add-on' label for a broad range of bioassays improves th
76 approach of performing regularisation as an add-on layer after the completion of image registration
78 adionuclide MPI and two supplementary codes (add-on left ventricular wall motion or left ventricular
80 anized anti-IL-5 monoclonal antibody used as add-on maintenance treatment for patients with uncontrol
81 n = 119) or AZA (75 to 125 mg/day, n = 114) added-on maintenance low-dose CsA microemulsion and 1-we
82 ose inhaled corticosteroids (ICSs) or ICSs + add-on medication (long-acting beta2-agonist [LABA], leu
83 Given that roflumilast is recommended as an "add-on" medication to patients with severe disease who w
84 on the reasoning behind the use of different add-on medications for severe asthma, and crucially, on
87 dence suggested that, compared with placebo, add-on memantine inconsistently improved cognition and i
91 e based TIRF system that could be used as an add-on module to any standard fluorescence microscope ev
95 but that the HNK-1 glycan is preferentially added on N-glycans over O-glycans of NCAM, probably beca
96 he average maximum willingness to pay for an add-on NS-LLT as a daily, oral medication without side e
97 12 sets of experimentally designed pairs of add-on NS-LLT profiles that varied in efficacy, administ
100 pped down by dropping their LABAs or another add-on or by halving their ICS dose (halving their mean-
105 IPPS, Medicare established a New Technology Add-on Payment for Viz.ai software, an AI algorithm that
109 This overview also includes supplementary (add-on; piggyback) lenses implanted in eyes that are alr
111 therefore, not be routinely performed as an add-on procedure to tympanoplasty for this indication.
116 on a low-cost brightfield microscope with an add-on pulsed light source, BS-IDT recovers both infrare
122 which 2220 patients were assigned to receive add-on rosiglitazone (rosiglitazone group), and 2227 to
124 hat ILs adopt a role as a preconcentrator to add on sensitivity with enhanced selectivity coming from
127 es at 3 years was significantly lower in the add-on SLIT group than in the standard treatment group (
128 erated dose of background therapy to receive add-on sotatercept (starting dose, 0.3 mg per kilogram o
131 d, placebo-controlled, crossover, randomised add-on study in which 100 patients with asthma and sympt
133 feron beta were randomly assigned to receive add-on subcutaneous daclizumab 2 mg/kg every 2 weeks (in
136 g preformed DSA using bead-based assay as an add-on test to complement-dependent cytotoxicity (CDC) c
141 endogenous anti-inflammatory mechanism as an add-on therapeutic strategy for specific forms of epilep
143 ids might be useful in guiding the choice of add-on therapies in each child as a step toward achievin
144 utide or sitagliptin and then reported these add-on therapies to be novel pharmacotherapeutic therapi
145 laying cards, bingo, Jenga, or ball game) as add-on therapies to conventional rehabilitation over a 2
146 On the basis of less evidence, results for add-on therapies to metformin were similar to those for
150 s, allopurinol is proving to be an effective add on therapy with good resultant disease control and l
151 itor ezetimibe may offer a viable option for add on therapy; however, questions have been raised rega
152 randomized in a 1:1 ratio to either Peg-IFN add-on therapy (180 microg/week) from week 24 to 48 (n =
154 ts occurred in 36 patients (24.7%) receiving add-on therapy and 29 (28.2%) receiving substitution mon
155 TF occurred in 48 patients (32.9%) receiving add-on therapy and 36 (35.0%) using substitution monothe
158 re assessed in the AsthmaNet VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness) t
159 eroids who are treated with omalizumab as an add-on therapy experience only modest benefits in sympto
161 acy and safety of subcutaneous omalizumab as add-on therapy for 24 weeks in patients with chronic idi
163 d enrolled onto the Environmental Control as Add-on Therapy for Childhood Asthma study were evaluated
165 s the efficacy and safety of benralizumab as add-on therapy for patients with severe, uncontrolled as
166 2018 recommends SGLT inhibitors as preferred add-on therapy for patients with type 2 diabetes and est
168 and 13% fluticasone/montelukast in the Best ADd-on Therapy Giving Effective Responses trial; P = .01
169 placebo, tiotropium 5 mug, but not 2.5 mug, add-on therapy improved the primary end point, peak FEV1
170 nt reduces airway hyper-responsiveness as an add-on therapy in adult asthmatics on inhaled corticoste
172 rimary therapy in functional heartburn or as add-on therapy in functional heartburn that overlaps wit
173 ntinuous theta burst stimulation is a viable add-on therapy in neglect rehabilitation that facilitate
177 sess the efficacy and safety of dupilumab as add-on therapy in patients with uncontrolled persistent
179 s, they may have the potential to be used as add-on therapy in the treatment of schizophrenia, a dise
180 lic acid intolerance, conditionally licensed add-on therapy is with the FXR (NR1H4) agonist, obeticho
181 ndpoint was not reached, 24 weeks of Peg-IFN add-on therapy led to a higher proportion of HBeAg respo
183 ion (enalapril 20 mg/day) were randomized to add-on therapy of spironolactone 25 mg, hydrochlorothiaz
186 ults suggest that metformin could be used as add-on therapy to a conventional antidepressant for the
188 f depigmented polymerized mite extract as an add-on therapy to basic (ie, topical and, as necessary,
189 t poor in BCAAs, provided either alone or as add-on therapy to conventional antidepressant drugs, cou
190 neous CYT003 (0.3, 1, or 2 mg) or placebo as add-on therapy to conventional controller medication.
191 airment, non-immersive virtual reality as an add-on therapy to conventional rehabilitation was not su
192 and safety of once-daily tiotropium Respimat add-on therapy to high-dose ICS with 1 or more controlle
193 oved lung function and was well tolerated as add-on therapy to ICS with other maintenance therapies i
194 ffect of salmeterol versus montelukast as an add-on therapy to ICS within 16 weeks of follow-up (the
195 strated that tiotropium is efficacious as an add-on therapy to inhaled corticosteroids (ICSs) with or
196 ptor antagonists either as monotherapy or as add-on therapy to inhaled corticosteroids increased FEV1
199 s with bouts of OHE, intravenous LOLA (as an add-on therapy to lactulose and ceftriaxone) significant
201 .33 to 0.56]) compared with sulfonylureas as add-on therapy to metformin but had no effect on risks f
204 fety and efficacy of inhaled treprostinil as add-on therapy to oral bosentan in patients with pulmona
209 nterleukin-5 monoclonal antibody approved as add-on therapy to standard of care for patients with sev
210 sound neuromodulation could serve as a novel add-on therapy to standard treatments for Alzheimer dise
211 cribes a randomized, open study of clozapine add-on therapy versus treatment as usual for patients wi
212 dication (MED) and were randomly assigned to add-on therapy with cognitive-behavioral group therapy (
213 herapy and were randomly assigned to receive add-on therapy with either placebo (placebo-minus group,
215 ognitive-behavioral group therapy (CBT-arm), add-on therapy with ultra-brief pulse continuation elect
216 ophagy-inducing drugs, such as spermidine or add-on therapy with widely used antiatherogenic compound
218 ated to standard blood pressure targets with add-on therapy, excluding other inhibitors of the renin-
225 ns, compared with male surgeons, had shorter add-on times for urgent and emergent operation, with an
229 ve but not conclusive evidence for use as an add-on to a statin for patients reaching low-density lip
230 bel information about Vascepa (ie, use as an add-on to a statin) from the manufacturer, and 16% had p
231 e efficacy and safety of dapagliflozin as an add-on to adjustable insulin in patients with inadequate
232 igen [HBeAg] positive) or started PEG-IFN as add-on to an existing nucleo(s)tide analogue backbone (n
239 bo group) and when it was administered as an add-on to fibrates (decreases of 60.2+/-12.5% in the 200
241 aimed to study the effect of metformin as an add-on to insulin therapy on periodontal structures duri
246 entions included monotherapies (134 trials), add-on to metformin-based therapies (296 trials), and mo
251 Our findings suggest that bumetanide as an add-on to phenobarbital does not improve seizure control
252 feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizur
254 f-directed gamified cognitive training as an add-on to standard therapy during post-acute inpatient n
257 Risk Screening (PARIS) study, a prospective add-on to the Imaging Dementia-Evidence for Amyloid Scan
260 0 days in comparators, 311 days for imipenem added on to a failing regimen, and 37 days in newly trea
261 ound to mediate a phase that can be flexibly added on to both ingestive and egestive-rejection progra
262 , in which the study treatment or placebo is added on to known effective treatment, may also be used
263 Expression of late-onset pri-mir-9-1 is added on to, rather than replacing, the expression of ea
264 onal therapies as a substitute for or as an "add on" to conventional medical treatments is uncertain.
265 ground (S(0)) and excited (S(1)) states that add on top of smaller shifts predicted already for these
267 esistant were randomly assigned to clozapine add-on treatment (N = 19) or treatment as usual (no cloz
269 results do not suggest benefit of LMTM as an add-on treatment for patients with mild to moderate Alzh
270 tinib, 200 mg daily, is well tolerated as an add-on treatment for pulmonary arterial hypertension.
271 e efficacy and safety of empagliflozin as an add-on treatment in patients with type 2 diabetes and CK
272 tly, we demonstrated that azithromycin (AZM) add-on treatment in patients with uncontrolled moderate-
275 pport the use of mepolizumab as a favourable add-on treatment option to standard of care in patients
278 h the Respimat device every evening, each as add-on treatment to ICS background therapy, with or with
283 itors of antibiotic resistance mechanisms as add-on treatments for serious drug-resistant infections.
285 re clinical assessment will probably include add-on trials in which a new drug is combined with an in
286 or, the interpretation of placebo controlled add-on trials is straightforward as they have the capaci
287 increase GABAergic function, and may justify add-on trials of the NKCC1 inhibitor bumetanide for the
289 including placebo-controlled monotherapy or add-on trials, noninferiority studies, and withdrawal tr
290 nsiderations, and the emergence of data from add-on trials, we believe that the future of management
292 CIEF has a potential of becoming a practical add-on unit in a wide range of bioanalytical setups, in
293 , 2.00; 95% CI, 1.43-2.79), regular ICS plus add-on use (HR, 1.63; 95% CI, 1.37-1.94), or with freque
294 me, the performance of this novel CE and the add-on value of the 344 degrees -viewing in a multi-cent
299 NA levels before randomized therapy, Peg-IFN add-on was significantly associated with response (odds